Structure

Physi-Chem Properties

Molecular Weight:  471.22
Volume:  454.679
LogP:  0.551
LogD:  0.736
LogS:  -1.523
# Rotatable Bonds:  9
TPSA:  160.88
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.328
Synthetic Accessibility Score:  3.939
Fsp3:  0.455
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.754
MDCK Permeability:  5.135556421009824e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.985
Human Intestinal Absorption (HIA):  0.861
20% Bioavailability (F20%):  0.587
30% Bioavailability (F30%):  0.503

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.491
Plasma Protein Binding (PPB):  50.3372802734375%
Volume Distribution (VD):  1.43
Pgp-substrate:  52.67213439941406%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.078
CYP2C19-inhibitor:  0.044
CYP2C19-substrate:  0.1
CYP2C9-inhibitor:  0.015
CYP2C9-substrate:  0.064
CYP2D6-inhibitor:  0.011
CYP2D6-substrate:  0.282
CYP3A4-inhibitor:  0.482
CYP3A4-substrate:  0.198

ADMET: Excretion

Clearance (CL):  9.529
Half-life (T1/2):  0.756

ADMET: Toxicity

hERG Blockers:  0.111
Human Hepatotoxicity (H-HT):  0.484
Drug-inuced Liver Injury (DILI):  0.98
AMES Toxicity:  0.351
Rat Oral Acute Toxicity:  0.213
Maximum Recommended Daily Dose:  0.217
Skin Sensitization:  0.138
Carcinogencity:  0.61
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.38

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC160666

Natural Product ID:  NPC160666
Common Name*:   Puromycin
IUPAC Name:   (2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
Synonyms:   3123L; CL-13900; GNF-Pf-2016; P-638; Puromycin; TCMDC-123493
Standard InCHIKey:  RXWNCPJZOCPEPQ-NVWDDTSBSA-N
Standard InCHI:  InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1
SMILES:  CN(C)c1c2c(ncn1)n(cn2)[C@H]1[C@@H]([C@@H]([C@@H](CO)O1)N=C([C@H](Cc1ccc(cc1)OC)N)O)O
Synthetic Gene Cluster:   BGC0000878;
ChEMBL Identifier:   CHEMBL469912
PubChem CID:   439530
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000289] Nucleosides, nucleotides, and analogues
      • [CHEMONTID:0000479] Purine nucleosides
        • [CHEMONTID:0002178] Purine 3'-deoxyribonucleosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO448 Millettia usaramensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[26651537]
NPO40074 Cleistochlamys kirkii Species Annonaceae Eukaryota Leaves n.a. n.a. PMID[28001067]
NPO40120 Eremophila microtheca Species Scrophulariaceae Eukaryota Aerial Parts n.a. n.a. PMID[28774427]
NPO40135 Flindersia pimenteliana Species Rutaceae Eukaryota Leaves n.a. n.a. PMID[29236492]
NPO40215 Streptomyces sp. CB01388 Strain Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[29469575]
NPO40120 Eremophila microtheca Species Scrophulariaceae Eukaryota n.a. n.a. n.a. PMID[29533611]
NPO40089 Corymbia torelliana Species Myrtaceae Eukaryota n.a. n.a. n.a. PMID[29969262]
NPO40229 Streptomyces sp. PU-14G Strain Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[30418763]
NPO40003 Acronychia pubescens Species Rutaceae Eukaryota Roots n.a. n.a. PMID[30865443]
NPO41040 Sphaerocoryne gracilis ssp. gracilis Strain Annonaceae Eukaryota n.a. n.a. n.a. PMID[32067457]
NPO40732 Amathia lamourouxi Species n.a. n.a. n.a. n.a. n.a. PMID[33105995]
NPO448 Millettia usaramensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO448 Millettia usaramensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus IC50 = 0.5 ug.mL-1 PMID[568796]
NPT168 Cell Line P388 Mus musculus Inhibition = 64.0 % PMID[568798]
NPT4849 Cell Line P815 Mus musculus Inhibition = 98.0 % PMID[568798]
NPT4850 Cell Line Osteoclast-like Inhibition = 61.0 % PMID[568798]
NPT137 Cell Line L1210 Mus musculus Log CR = 1.82 n.a. PMID[568799]
NPT1161 Cell Line CHO Cricetulus griseus Log CR = 2.02 n.a. PMID[568799]
NPT1178 Cell Line KB 3-1 Homo sapiens IC50 = 378000.0 nM PMID[568805]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 230.0 nM PMID[568805]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 83930.0 nM PMID[568805]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 364000.0 nM PMID[568805]
NPT111 Cell Line K562 Homo sapiens IC50 = 220.0 nM PMID[568805]
NPT111 Cell Line K562 Homo sapiens IC50 = 26830.0 nM PMID[568805]
NPT111 Cell Line K562 Homo sapiens IC50 = 122000.0 nM PMID[568805]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 210.0 nM PMID[568806]
NPT65 Cell Line HepG2 Homo sapiens Inhibition = 99.0 % PMID[568808]
NPT1229 Cell Line Huh-7 Homo sapiens CC50 = 6630.0 nM PMID[568809]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 420.0 nM PMID[568810]
NPT531 Individual Protein Nuclear receptor ROR-gamma Mus musculus Potency = 22387.2 nM PMID[568813]
NPT531 Individual Protein Nuclear receptor ROR-gamma Mus musculus Potency = 17782.8 nM PMID[568813]
NPT71 Cell Line HEK293 Homo sapiens GI = 100.0 % PMID[568822]
NPT2257 Cell Line MCF-10A Homo sapiens GI = 100.0 % PMID[568822]
NPT845 Cell Line BT-474 Homo sapiens GI = 100.0 % PMID[568822]
NPT461 Cell Line PANC-1 Homo sapiens GI = 100.0 % PMID[568822]
NPT1081 Cell Line BXPC-3 Homo sapiens GI = 100.0 % PMID[568822]
NPT1182 Cell Line J774.A1 Mus musculus IC50 = 10000.0 nM PMID[568823]
NPT66 Individual Protein Acetylcholinesterase Electrophorus electricus Inhibition = -7.92 % PMID[568824]
NPT49 Individual Protein DNA-(apurinic or apyrimidinic site) lyase Homo sapiens Potency n.a. 1.8 nM PMID[568813]
NPT4852 Individual Protein Puromycin-sensitive aminopeptidase Homo sapiens IC50 = 2450.0 nM PMID[568833]
NPT1553 Individual Protein Aminopeptidase N Sus scrofa IC50 > 100000.0 nM PMID[568833]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 361.0 nM PMID[568834]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 350.5 nM PMID[568835]
NPT81 Cell Line A549 Homo sapiens IC50 = 600.0 nM PMID[568836]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 0.35 nM PMID[568837]
NPT82 Cell Line MDA-MB-231 Homo sapiens CC50 = 480.0 nM PMID[568839]
NPT783 Cell Line MIA PaCa-2 Homo sapiens CC50 = 200.0 nM PMID[568839]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 360.0 nM PMID[568840]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 399.0 nM PMID[568841]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 460.0 nM PMID[568842]
NPT4852 Individual Protein Puromycin-sensitive aminopeptidase Homo sapiens IC50 = 9700.0 nM PMID[568843]
NPT2553 Individual Protein Aminopeptidase N Homo sapiens Inhibition = 15.7 % PMID[568843]
NPT2553 Individual Protein Aminopeptidase N Homo sapiens IC50 = 41000.0 nM PMID[568843]
NPT165 Cell Line HeLa Homo sapiens Inhibition = 99.0 % PMID[568843]
NPT189 Cell Line Vero Chlorocebus aethiops CC50 = 2800.0 nM PMID[568843]
NPT116 Cell Line HL-60 Homo sapiens EC50 = 55.0 nM PMID[568843]
NPT112 Cell Line MOLT-4 Homo sapiens EC50 = 170.0 nM PMID[568843]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 450.0 nM PMID[568844]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 400.0 nM PMID[568845]
NPT65 Cell Line HepG2 Homo sapiens pCC50 = 6.3 n.a. PMID[568846]
NPT180 Cell Line HCT-8 Homo sapiens EC50 = 6100.0 nM PMID[568847]
NPT2615 Cell Line HEK-293T Homo sapiens CC50 = 420.0 nM PMID[568847]
NPT65 Cell Line HepG2 Homo sapiens CC50 = 830.0 nM PMID[568847]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 460.0 nM PMID[568848]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 300.0 nM PMID[568849]
NPT81 Cell Line A549 Homo sapiens IC50 = 300.0 nM PMID[568849]
NPT71 Cell Line HEK293 Homo sapiens CC50 = 500.1 nM PMID[568850]
NPT71 Cell Line HEK293 Homo sapiens GI = 104.9 % PMID[568850]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens IC50 = 18000000.0 nM PMID[568852]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 694.0 nM PMID[568854]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 360.0 nM PMID[568855]
NPT71 Cell Line HEK293 Homo sapiens CC50 = 230.0 nM PMID[568857]
NPT71 Cell Line HEK293 Homo sapiens IC50 = 810.0 nM PMID[568858]
NPT2 Others Unspecified Km = 134000.0 nM PMID[568797]
NPT2 Others Unspecified Vmax = 0.99 pM min-1 PMID[568797]
NPT2 Others Unspecified Substrate efficiency = 100.0 % PMID[568797]
NPT2 Others Unspecified Log CR = 1.92 n.a. PMID[568799]
NPT35 Others n.a. LogD = 0.86 n.a. PMID[568799]
NPT19 Organism Escherichia coli Escherichia coli Km = 186000.0 nM PMID[568800]
NPT29 Organism Rattus norvegicus Rattus norvegicus Km = 255000.0 nM PMID[568800]
NPT2 Others Unspecified Vmax = 1890.0 c.p.m. PMID[568800]
NPT2 Others Unspecified Vmax = 14214.0 c.p.m. PMID[568800]
NPT2 Others Unspecified Efficiency = 100.0 % PMID[568800]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 0.3 ug ml-1 PMID[568800]
NPT2 Others Unspecified Ratio = 10161.0 n.a. PMID[568800]
NPT2 Others Unspecified Ratio = 55741.0 n.a. PMID[568800]
NPT25183 SINGLE PROTEIN Dihydrofolate reductase Mus musculus Log 1/C = 6.46 n.a. PMID[568801]
NPT25183 SINGLE PROTEIN Dihydrofolate reductase Mus musculus Log 1/C = 6.41 n.a. PMID[568801]
NPT35 Others n.a. LogP = 0.03 n.a. PMID[568801]
NPT19 Organism Escherichia coli Escherichia coli Ki = 220000.0 nM PMID[568802]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC = 0.312 ug.mL-1 PMID[568803]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 210.0 nM PMID[568805]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 79300.0 nM PMID[568805]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 20200.0 nM PMID[568806]
NPT2 Others Unspecified Inhibition = 0.0 % PMID[568807]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Inhibition = 0.0 % PMID[568808]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Inhibition = 100.0 % PMID[568808]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum XC50 = 174.18 nM PMID[568808]
NPT2 Others Unspecified IFI = 8.45 % PMID[568808]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 = 611.0 nM PMID[568809]
NPT2 Others Unspecified IFI = 30.77 % PMID[568809]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 = 328.0 nM PMID[568809]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 37.0 nM PMID[568810]
NPT19 Organism Escherichia coli Escherichia coli Activity = 25.0 % PMID[568811]
NPT317 Uncleic Acid Nucleic Acid EC50 = 100.0 nM PMID[568811]
NPT317 Uncleic Acid Nucleic Acid Activity > 1.0 uM PMID[568811]
NPT25608 PROTEIN NUCLEIC-ACID COMPLEX Bacterial 70S ribosome Bacteria IC50 = 900.0 nM PMID[568812]
NPT2 Others Unspecified Potency = 707.9 nM PMID[568813]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Papp = 11.5 nm/s PMID[568818]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Papp = 35.6 nm/s PMID[568818]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Ratio_Papp = 3.1 n.a. PMID[568818]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens Ratio_ATPase activity = 1.21 n.a. PMID[568818]
NPT668 Individual Protein P-glycoprotein 1 Homo sapiens % maximum response = 1.91 % PMID[568818]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 89.0 nM PMID[568822]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 100.0 % PMID[568822]
NPT67 Individual Protein Cholinesterase Equus caballus Inhibition = -9.98 % PMID[568824]
NPT2759 Organism Streptomyces acidiscabies Streptomyces acidiscabies IZ = 20.0 mm PMID[568825]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 64.0 nM PMID[568826]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 46.0 nM PMID[568826]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 137.0 nM PMID[568826]
NPT2 Others Unspecified Potency n.a. 1258.9 nM PMID[568813]
NPT2 Others Unspecified Potency n.a. 6309.6 nM PMID[568813]
NPT25608 PROTEIN NUCLEIC-ACID COMPLEX Bacterial 70S ribosome Bacteria Km = 234000.0 nM PMID[568827]
NPT25608 PROTEIN NUCLEIC-ACID COMPLEX Bacterial 70S ribosome Bacteria Vmax = 3.99 pmol/min PMID[568827]
NPT2258 Organism Plasmodium falciparum NF54 Plasmodium falciparum NF54 IC50 = 194.0 nM PMID[568828]
NPT2258 Organism Plasmodium falciparum NF54 Plasmodium falciparum NF54 IC50 = 175.0 nM PMID[568828]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei Activity = 100.0 % PMID[568829]
NPT942 Individual Protein Glucose transporter Homo sapiens Inhibition = 3.7 % PMID[568830]
NPT943 Individual Protein Hexose transporter 1 Plasmodium falciparum Inhibition = 1.9 % PMID[568830]
NPT944 Individual Protein Glucose transporter Leishmania mexicana Inhibition = 3.16 % PMID[568830]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 42.0 nM PMID[568831]
NPT2 Others Unspecified Kd = 11800.0 nM PMID[568832]
NPT2 Others Unspecified Kd = 5850.0 nM PMID[568832]
NPT2 Others Unspecified Kd = 12700.0 nM PMID[568832]
NPT2 Others Unspecified IC50 > 100000.0 nM PMID[568833]
NPT757 Organism Plasmodium falciparum 3D7 Plasmodium falciparum 3D7 IC50 = 22.7 nM PMID[568834]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 45.2 nM PMID[568834]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 700.0 nM PMID[568836]
NPT757 Organism Plasmodium falciparum 3D7 Plasmodium falciparum 3D7 IC50 = 60.0 nM PMID[568837]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 62.0 nM PMID[568837]
NPT27 Others Unspecified Ratio IC50 = 6.0 n.a. PMID[568837]
NPT2 Others Unspecified Kd = 480000.0 nM PMID[568838]
NPT2 Others Unspecified Ratio IC50 = 15.9 n.a. PMID[568840]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 45.0 nM PMID[568840]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 23.0 nM PMID[568840]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 61.0 nM PMID[568841]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 62.0 nM PMID[568841]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 53.2 nM PMID[568842]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 43.8 nM PMID[568842]
NPT2 Others Unspecified Ratio IC50 = 1.16 n.a. PMID[568842]
NPT2 Others Unspecified Ratio IC50 = 9.0 n.a. PMID[568842]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 32.0 nM PMID[568844]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 53.0 nM PMID[568844]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 100.0 % PMID[568844]
NPT2 Others Unspecified Ratio IC50 = 8.0 n.a. PMID[568844]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 60.0 nM PMID[568845]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 61.0 nM PMID[568845]
NPT1022 Organism Cryptosporidium parvum Cryptosporidium parvum EC50 = 600.0 nM PMID[568847]
NPT1022 Organism Cryptosporidium parvum Cryptosporidium parvum EC50 = 550.0 nM PMID[568847]
NPT2 Others Unspecified Ratio IC50 = 10.5 n.a. PMID[568848]
NPT2 Others Unspecified Ratio IC50 = 9.0 n.a. PMID[568848]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 44.0 nM PMID[568848]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 53.0 nM PMID[568848]
NPT19 Organism Escherichia coli Escherichia coli MIC <= 120000.0 nM PMID[568849]
NPT5246 Organism Mycobacterium aurum Mycobacterium aurum MIC = 4000.0 nM PMID[568849]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 4000.0 nM PMID[568849]
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC = 4000.0 nM PMID[568849]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 4000.0 nM PMID[568849]
NPT1190 Organism Salmonella enterica Salmonella enterica MIC <= 120000.0 nM PMID[568849]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC <= 120000.0 nM PMID[568849]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 110.8 nM PMID[568850]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 106.6 nM PMID[568850]
NPT2 Others Unspecified Ratio CC50/IC50 = 4.5 n.a. PMID[568850]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 50.0 nM PMID[568851]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 50.12 nM PMID[568851]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 410.0 nM PMID[568853]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 70.2 nM PMID[568854]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 74.7 nM PMID[568854]
NPT2 Others Unspecified Ratio IC50 = 9.9 n.a. PMID[568854]
NPT2 Others Unspecified Ratio IC50 = 1.1 n.a. PMID[568854]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 23.0 nM PMID[568855]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 45.0 nM PMID[568855]
NPT2 Others Unspecified Ratio IC50 = 15.9 n.a. PMID[568855]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 51.97 nM PMID[568856]
NPT2 Others Unspecified Ratio IC50 = 8.0 n.a. PMID[568856]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 38.0 nM PMID[568857]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 110.0 nM PMID[568858]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 68.0 nM PMID[568858]
NPT2 Others Unspecified Ratio IC50 = 353.0 n.a. PMID[568858]
NPT2 Others Unspecified Ratio IC50 = 585.0 n.a. PMID[568858]
NPT27734 CELL-LINE SU-DHL10 Homo sapiens CC50 = 110.0 nM PMID[568839]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC160666 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9135 High Similarity NPC250178
0.7917 Intermediate Similarity NPC150447
0.7895 Intermediate Similarity NPC21461
0.7773 Intermediate Similarity NPC115595
0.7686 Intermediate Similarity NPC107160
0.7613 Intermediate Similarity NPC242923
0.7563 Intermediate Similarity NPC477796
0.7563 Intermediate Similarity NPC477805
0.7563 Intermediate Similarity NPC477806
0.7563 Intermediate Similarity NPC477795
0.7479 Intermediate Similarity NPC472067
0.7479 Intermediate Similarity NPC472031
0.7479 Intermediate Similarity NPC472066
0.7469 Intermediate Similarity NPC472068
0.7456 Intermediate Similarity NPC308906
0.7342 Intermediate Similarity NPC158055
0.7327 Intermediate Similarity NPC280638
0.7297 Intermediate Similarity NPC103388
0.729 Intermediate Similarity NPC313514
0.7222 Intermediate Similarity NPC35761
0.7203 Intermediate Similarity NPC237978
0.7178 Intermediate Similarity NPC30540
0.7155 Intermediate Similarity NPC136924
0.7137 Intermediate Similarity NPC469589
0.7137 Intermediate Similarity NPC46970
0.7118 Intermediate Similarity NPC471603
0.7112 Intermediate Similarity NPC469594
0.7106 Intermediate Similarity NPC130570
0.7087 Intermediate Similarity NPC469592
0.7087 Intermediate Similarity NPC471080
0.7069 Intermediate Similarity NPC12100
0.7056 Intermediate Similarity NPC50511
0.7054 Intermediate Similarity NPC223223
0.7028 Intermediate Similarity NPC56271
0.7017 Intermediate Similarity NPC110151
0.7008 Intermediate Similarity NPC471614
0.6966 Remote Similarity NPC467439
0.6949 Remote Similarity NPC17305
0.6927 Remote Similarity NPC239737
0.6917 Remote Similarity NPC314954
0.6905 Remote Similarity NPC314882
0.6895 Remote Similarity NPC472434
0.6883 Remote Similarity NPC171393
0.6883 Remote Similarity NPC295452
0.6883 Remote Similarity NPC113369
0.6856 Remote Similarity NPC472111
0.6842 Remote Similarity NPC99891
0.6831 Remote Similarity NPC328924
0.6824 Remote Similarity NPC26679
0.6815 Remote Similarity NPC39092
0.6814 Remote Similarity NPC18487
0.6809 Remote Similarity NPC288349
0.6807 Remote Similarity NPC310118
0.6805 Remote Similarity NPC323244
0.6805 Remote Similarity NPC187145
0.6787 Remote Similarity NPC472289
0.6784 Remote Similarity NPC19872
0.6769 Remote Similarity NPC315467
0.6762 Remote Similarity NPC469554
0.6754 Remote Similarity NPC232727
0.6744 Remote Similarity NPC313897
0.6743 Remote Similarity NPC478009
0.6737 Remote Similarity NPC8022
0.6737 Remote Similarity NPC470799
0.6726 Remote Similarity NPC267928
0.6723 Remote Similarity NPC193267
0.6723 Remote Similarity NPC213530
0.6719 Remote Similarity NPC51854
0.6704 Remote Similarity NPC477633
0.6695 Remote Similarity NPC185782
0.668 Remote Similarity NPC9729
0.6667 Remote Similarity NPC279401
0.6667 Remote Similarity NPC478006
0.6667 Remote Similarity NPC219963
0.6667 Remote Similarity NPC472436
0.6667 Remote Similarity NPC470500
0.6667 Remote Similarity NPC144114
0.6667 Remote Similarity NPC79293
0.6667 Remote Similarity NPC161887
0.6667 Remote Similarity NPC226202
0.6653 Remote Similarity NPC184680
0.6653 Remote Similarity NPC266931
0.6638 Remote Similarity NPC176538
0.6634 Remote Similarity NPC150853
0.6627 Remote Similarity NPC470785
0.6623 Remote Similarity NPC475774
0.6623 Remote Similarity NPC223427
0.6617 Remote Similarity NPC478011
0.6616 Remote Similarity NPC478010
0.6615 Remote Similarity NPC472435
0.6613 Remote Similarity NPC295228
0.6605 Remote Similarity NPC222174
0.6598 Remote Similarity NPC60621
0.6596 Remote Similarity NPC123976
0.6596 Remote Similarity NPC5145
0.6596 Remote Similarity NPC167860
0.6593 Remote Similarity NPC84853
0.6592 Remote Similarity NPC314176
0.6587 Remote Similarity NPC316756
0.6587 Remote Similarity NPC469975
0.6584 Remote Similarity NPC125597
0.6581 Remote Similarity NPC287208
0.6581 Remote Similarity NPC475910
0.6571 Remote Similarity NPC476997
0.6569 Remote Similarity NPC238945
0.6569 Remote Similarity NPC309832
0.6565 Remote Similarity NPC121772
0.6564 Remote Similarity NPC63109
0.6562 Remote Similarity NPC230805
0.656 Remote Similarity NPC470784
0.6559 Remote Similarity NPC101543
0.6556 Remote Similarity NPC132642
0.6553 Remote Similarity NPC174758
0.6552 Remote Similarity NPC245816
0.6552 Remote Similarity NPC476138
0.6545 Remote Similarity NPC476998
0.6545 Remote Similarity NPC476996
0.654 Remote Similarity NPC314056
0.654 Remote Similarity NPC203168
0.6537 Remote Similarity NPC54537
0.6532 Remote Similarity NPC180504
0.6531 Remote Similarity NPC244536
0.653 Remote Similarity NPC477634
0.6525 Remote Similarity NPC219664
0.6522 Remote Similarity NPC187558
0.652 Remote Similarity NPC28945
0.652 Remote Similarity NPC189068
0.6516 Remote Similarity NPC477891
0.6516 Remote Similarity NPC98371
0.6516 Remote Similarity NPC266551
0.6516 Remote Similarity NPC313884
0.6512 Remote Similarity NPC125659
0.6512 Remote Similarity NPC168702
0.6507 Remote Similarity NPC208751
0.6504 Remote Similarity NPC315822
0.6504 Remote Similarity NPC476994
0.6502 Remote Similarity NPC62510
0.6494 Remote Similarity NPC474183
0.6494 Remote Similarity NPC315957
0.6493 Remote Similarity NPC478012
0.6488 Remote Similarity NPC219313
0.6483 Remote Similarity NPC174672
0.6475 Remote Similarity NPC74619
0.6471 Remote Similarity NPC202605
0.6471 Remote Similarity NPC21448
0.6471 Remote Similarity NPC112206
0.6471 Remote Similarity NPC156461
0.6471 Remote Similarity NPC107374
0.6466 Remote Similarity NPC141053
0.6466 Remote Similarity NPC478013
0.6466 Remote Similarity NPC220852
0.6463 Remote Similarity NPC251090
0.6461 Remote Similarity NPC473317
0.6458 Remote Similarity NPC170114
0.6453 Remote Similarity NPC264166
0.6453 Remote Similarity NPC285558
0.6453 Remote Similarity NPC475070
0.6453 Remote Similarity NPC118832
0.6453 Remote Similarity NPC165349
0.6453 Remote Similarity NPC329708
0.6453 Remote Similarity NPC47059
0.6453 Remote Similarity NPC274291
0.6452 Remote Similarity NPC164664
0.6447 Remote Similarity NPC307963
0.6445 Remote Similarity NPC471891
0.6443 Remote Similarity NPC81175
0.6441 Remote Similarity NPC476465
0.6441 Remote Similarity NPC82548
0.6439 Remote Similarity NPC164665
0.6438 Remote Similarity NPC5802
0.6438 Remote Similarity NPC317054
0.6437 Remote Similarity NPC258048
0.6434 Remote Similarity NPC280272
0.6431 Remote Similarity NPC284141
0.6429 Remote Similarity NPC20249
0.6426 Remote Similarity NPC89987
0.6426 Remote Similarity NPC472286
0.6426 Remote Similarity NPC472287
0.6423 Remote Similarity NPC2497
0.6423 Remote Similarity NPC103687
0.6423 Remote Similarity NPC132631
0.6422 Remote Similarity NPC476688
0.6422 Remote Similarity NPC105758
0.6422 Remote Similarity NPC476686
0.6417 Remote Similarity NPC470549
0.641 Remote Similarity NPC157821
0.6408 Remote Similarity NPC269827
0.6406 Remote Similarity NPC278874
0.6405 Remote Similarity NPC303658
0.6404 Remote Similarity NPC324149
0.6402 Remote Similarity NPC316981
0.64 Remote Similarity NPC323752
0.6397 Remote Similarity NPC473185
0.6397 Remote Similarity NPC476492
0.6396 Remote Similarity NPC473585
0.6395 Remote Similarity NPC31930
0.6395 Remote Similarity NPC26543
0.6395 Remote Similarity NPC276373
0.6393 Remote Similarity NPC208060
0.639 Remote Similarity NPC274982

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC160666 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8571 High Similarity NPD5703 Discontinued
0.8421 Intermediate Similarity NPD2965 Clinical (unspecified phase)
0.8387 Intermediate Similarity NPD3590 Clinical (unspecified phase)
0.8381 Intermediate Similarity NPD2876 Phase 3
0.8381 Intermediate Similarity NPD2877 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD2824 Phase 2
0.8243 Intermediate Similarity NPD6023 Discontinued
0.8233 Intermediate Similarity NPD2903 Clinical (unspecified phase)
0.8233 Intermediate Similarity NPD2902 Phase 2
0.8222 Intermediate Similarity NPD4080 Discontinued
0.8091 Intermediate Similarity NPD4555 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD5080 Phase 2
0.7873 Intermediate Similarity NPD5079 Phase 2
0.7838 Intermediate Similarity NPD7980 Clinical (unspecified phase)
0.7837 Intermediate Similarity NPD2152 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD1273 Discontinued
0.7718 Intermediate Similarity NPD8442 Discontinued
0.7713 Intermediate Similarity NPD6643 Discontinued
0.7712 Intermediate Similarity NPD6573 Phase 3
0.7712 Intermediate Similarity NPD6572 Phase 2
0.7686 Intermediate Similarity NPD6326 Phase 2
0.7686 Intermediate Similarity NPD6327 Phase 1
0.7672 Intermediate Similarity NPD4306 Phase 1
0.7665 Intermediate Similarity NPD6036 Suspended
0.7647 Intermediate Similarity NPD7486 Phase 1
0.7639 Intermediate Similarity NPD3602 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD7706 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD4713 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD4714 Approved
0.7534 Intermediate Similarity NPD34 Approved
0.7534 Intermediate Similarity NPD4715 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD534 Phase 2
0.7533 Intermediate Similarity NPD537 Phase 2
0.7532 Intermediate Similarity NPD4654 Phase 1
0.75 Intermediate Similarity NPD5949 Phase 3
0.75 Intermediate Similarity NPD1624 Phase 2
0.75 Intermediate Similarity NPD6856 Discontinued
0.7489 Intermediate Similarity NPD7051 Phase 3
0.7489 Intermediate Similarity NPD3838 Phase 3
0.7489 Intermediate Similarity NPD7050 Clinical (unspecified phase)
0.7489 Intermediate Similarity NPD7502 Clinical (unspecified phase)
0.7489 Intermediate Similarity NPD6760 Discontinued
0.7479 Intermediate Similarity NPD6243 Phase 3
0.7479 Intermediate Similarity NPD6244 Phase 3
0.747 Intermediate Similarity NPD3343 Phase 3
0.747 Intermediate Similarity NPD7273 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD5567 Approved
0.7422 Intermediate Similarity NPD6202 Discontinued
0.7417 Intermediate Similarity NPD7067 Approved
0.7417 Intermediate Similarity NPD7068 Approved
0.7412 Intermediate Similarity NPD7198 Clinical (unspecified phase)
0.7411 Intermediate Similarity NPD4495 Phase 1
0.7409 Intermediate Similarity NPD5486 Discontinued
0.7399 Intermediate Similarity NPD4612 Discontinued
0.7397 Intermediate Similarity NPD8250 Phase 2
0.7395 Intermediate Similarity NPD6605 Phase 3
0.7389 Intermediate Similarity NPD5868 Approved
0.7379 Intermediate Similarity NPD5116 Phase 1
0.7375 Intermediate Similarity NPD6473 Phase 1
0.7371 Intermediate Similarity NPD3043 Approved
0.7371 Intermediate Similarity NPD3042 Approved
0.7366 Intermediate Similarity NPD5644 Phase 1
0.7366 Intermediate Similarity NPD6351 Discovery
0.7357 Intermediate Similarity NPD6528 Phase 1
0.7344 Intermediate Similarity NPD5802 Phase 2
0.7342 Intermediate Similarity NPD6840 Approved
0.7336 Intermediate Similarity NPD4916 Discontinued
0.7328 Intermediate Similarity NPD5911 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD6772 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD7758 Approved
0.7324 Intermediate Similarity NPD7757 Approved
0.7321 Intermediate Similarity NPD5529 Phase 1
0.7321 Intermediate Similarity NPD5528 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD4599 Clinical (unspecified phase)
0.7311 Intermediate Similarity NPD5107 Clinical (unspecified phase)
0.7309 Intermediate Similarity NPD5458 Discontinued
0.7306 Intermediate Similarity NPD5875 Approved
0.7306 Intermediate Similarity NPD5878 Approved
0.7301 Intermediate Similarity NPD2540 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD6186 Approved
0.7292 Intermediate Similarity NPD5905 Phase 1
0.729 Intermediate Similarity NPD7138 Phase 2
0.7285 Intermediate Similarity NPD4459 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD4458 Phase 2
0.7284 Intermediate Similarity NPD1954 Phase 1
0.7277 Intermediate Similarity NPD2453 Phase 2
0.7277 Intermediate Similarity NPD2451 Phase 2
0.7277 Intermediate Similarity NPD2450 Phase 2
0.7277 Intermediate Similarity NPD2452 Phase 2
0.7276 Intermediate Similarity NPD6743 Phase 2
0.7276 Intermediate Similarity NPD6742 Phase 2
0.7273 Intermediate Similarity NPD7620 Phase 2
0.7273 Intermediate Similarity NPD4440 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD983 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD6750 Phase 2
0.7243 Intermediate Similarity NPD5044 Phase 2
0.7241 Intermediate Similarity NPD6589 Phase 1
0.7231 Intermediate Similarity NPD5833 Phase 1
0.7227 Intermediate Similarity NPD5018 Phase 3
0.7222 Intermediate Similarity NPD4132 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD3938 Phase 1
0.722 Intermediate Similarity NPD2929 Clinical (unspecified phase)
0.722 Intermediate Similarity NPD6992 Phase 2
0.7208 Intermediate Similarity NPD5920 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD6482 Phase 1
0.7195 Intermediate Similarity NPD5665 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD1287 Phase 2
0.7185 Intermediate Similarity NPD5627 Approved
0.7185 Intermediate Similarity NPD7705 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD4673 Phase 2
0.7176 Intermediate Similarity NPD3254 Phase 1
0.7176 Intermediate Similarity NPD3255 Phase 1
0.7156 Intermediate Similarity NPD7323 Phase 2
0.7155 Intermediate Similarity NPD6500 Approved
0.7155 Intermediate Similarity NPD6501 Approved
0.7149 Intermediate Similarity NPD4858 Phase 2
0.7149 Intermediate Similarity NPD7117 Phase 2
0.7143 Intermediate Similarity NPD4996 Approved
0.7143 Intermediate Similarity NPD4995 Approved
0.7132 Intermediate Similarity NPD6175 Phase 3
0.7126 Intermediate Similarity NPD6216 Approved
0.7124 Intermediate Similarity NPD796 Phase 2
0.7121 Intermediate Similarity NPD5509 Phase 1
0.7108 Intermediate Similarity NPD5539 Phase 2
0.7107 Intermediate Similarity NPD3849 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD2414 Clinical (unspecified phase)
0.7106 Intermediate Similarity NPD6197 Approved
0.7106 Intermediate Similarity NPD5045 Phase 2
0.7105 Intermediate Similarity NPD4048 Approved
0.7102 Intermediate Similarity NPD6774 Approved
0.7101 Intermediate Similarity NPD6708 Discontinued
0.7101 Intermediate Similarity NPD4925 Approved
0.7098 Intermediate Similarity NPD4442 Phase 2
0.7095 Intermediate Similarity NPD1259 Discontinued
0.7087 Intermediate Similarity NPD4457 Phase 2
0.7083 Intermediate Similarity NPD7558 Phase 2
0.708 Intermediate Similarity NPD2060 Approved
0.7077 Intermediate Similarity NPD6754 Phase 3
0.7076 Intermediate Similarity NPD5829 Phase 2
0.7074 Intermediate Similarity NPD3570 Phase 2
0.7074 Intermediate Similarity NPD949 Phase 1
0.7074 Intermediate Similarity NPD4131 Phase 3
0.7071 Intermediate Similarity NPD2062 Phase 2
0.7064 Intermediate Similarity NPD2410 Phase 2
0.7059 Intermediate Similarity NPD8421 Discontinued
0.7056 Intermediate Similarity NPD429 Approved
0.7054 Intermediate Similarity NPD2757 Phase 2
0.7035 Intermediate Similarity NPD1915 Phase 1
0.7032 Intermediate Similarity NPD1286 Suspended
0.7028 Intermediate Similarity NPD5008 Approved
0.702 Intermediate Similarity NPD5051 Phase 1
0.7016 Intermediate Similarity NPD3886 Phase 1
0.7009 Intermediate Similarity NPD2601 Approved
0.7009 Intermediate Similarity NPD2600 Approved
0.7009 Intermediate Similarity NPD2599 Approved
0.7008 Intermediate Similarity NPD6537 Approved
0.7008 Intermediate Similarity NPD6536 Approved
0.7005 Intermediate Similarity NPD2591 Phase 2
0.7004 Intermediate Similarity NPD5118 Phase 2
0.7 Intermediate Similarity NPD5139 Phase 1
0.6984 Remote Similarity NPD8049 Phase 2
0.698 Remote Similarity NPD6848 Phase 1
0.6979 Remote Similarity NPD5070 Clinical (unspecified phase)
0.6976 Remote Similarity NPD5876 Phase 3
0.6976 Remote Similarity NPD5877 Phase 3
0.6976 Remote Similarity NPD6450 Phase 2
0.6974 Remote Similarity NPD8410 Clinical (unspecified phase)
0.6964 Remote Similarity NPD1231 Phase 3
0.6951 Remote Similarity NPD5874 Phase 3
0.6951 Remote Similarity NPD5873 Phase 3
0.6949 Remote Similarity NPD4187 Clinical (unspecified phase)
0.6949 Remote Similarity NPD6381 Phase 2
0.6948 Remote Similarity NPD4896 Clinical (unspecified phase)
0.6937 Remote Similarity NPD978 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1258 Discontinued
0.6927 Remote Similarity NPD2646 Discontinued
0.6923 Remote Similarity NPD2530 Phase 2
0.6917 Remote Similarity NPD1571 Phase 2
0.691 Remote Similarity NPD4358 Clinical (unspecified phase)
0.6908 Remote Similarity NPD7898 Clinical (unspecified phase)
0.6908 Remote Similarity NPD7897 Phase 3
0.6903 Remote Similarity NPD6307 Clinical (unspecified phase)
0.69 Remote Similarity NPD2886 Approved
0.69 Remote Similarity NPD2885 Approved
0.69 Remote Similarity NPD1392 Approved
0.6894 Remote Similarity NPD6814 Phase 3
0.6891 Remote Similarity NPD5607 Discontinued
0.6889 Remote Similarity NPD3814 Phase 1
0.6889 Remote Similarity NPD4548 Discontinued
0.6888 Remote Similarity NPD1900 Clinical (unspecified phase)
0.688 Remote Similarity NPD5007 Approved
0.688 Remote Similarity NPD5612 Discontinued
0.6878 Remote Similarity NPD7726 Phase 1
0.6872 Remote Similarity NPD6223 Clinical (unspecified phase)
0.6872 Remote Similarity NPD2472 Approved
0.6872 Remote Similarity NPD2471 Approved
0.6867 Remote Similarity NPD2894 Phase 2
0.6867 Remote Similarity NPD7506 Discontinued
0.6866 Remote Similarity NPD8525 Approved
0.686 Remote Similarity NPD5052 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data